Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Proceedings of the National Academy of Sciences of the United States of America
Ted CohenMegan Murray

Abstract

In sub-Saharan Africa, where the emergence of HIV has caused dramatic increases in tuberculosis (TB) case notifications, new strategies for TB control are necessary. Isoniazid preventive therapy (IPT) for HIV-TB coinfected individuals reduces the reactivation of latent Mycobacterium tuberculosis infections and is being evaluated as a potential community-wide strategy for improving TB control. We developed a mathematical model of TB/HIV coepidemics to examine the impact of community-wide implementation of IPT for TB-HIV coinfected individuals on the dynamics of drug-sensitive and -resistant TB epidemics. We found that community-wide IPT will reduce the incidence of TB in the short-term but may also speed the emergence of drug-resistant TB. We conclude that community-wide IPT in areas of emerging HIV and drug-resistant TB should be coupled with diagnostic and treatment policies designed to identify and effectively treat the increasing proportion of patients with drug-resistant TB.

References

Aug 1, 1995·Nature Medicine·S M BlowerA R Moss
Jul 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·S J Heymann
Apr 22, 1996·Archives of Internal Medicine·N M GrahamD Vlahov
Sep 2, 1998·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S M Blower, J L Gerberding
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·C J Murray, J A Salomon
Aug 7, 1999·The Journal of Infectious Diseases·D van SoolingenJ D van Embden
Oct 16, 1999·The New England Journal of Medicine·A van RieP D van Helden
Oct 16, 1999·The New England Journal of Medicine·P E Fine, P M Small
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C Dye, B G Williams
Feb 24, 2001·American Journal of Epidemiology·E ZivS M Blower
Apr 25, 2002·Emerging Infectious Diseases·Marc Lipsitch, Matthew H Samore
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annika KrüünerMarika Mikelsaar
Jul 19, 2002·Proceedings. Biological Sciences·C Dye, M A Espinal
Dec 31, 2002·The Lancet Infectious Diseases·Ted CohenMegan Murray
Jan 10, 2003·The New England Journal of Medicine·Carole MitnickPaul Farmer
May 14, 2003·Archives of Internal Medicine·Elizabeth L CorbettChristopher Dye
Aug 16, 2003·Science·Brian G Williams, Christopher Dye
Nov 6, 2003·AIDS·Christine S M CurrieChristopher Dye
Dec 16, 2003·The Journal of Infectious Diseases·Marcos BurgosCharles L Daley
Jan 1, 2004·American Journal of Respiratory and Critical Care Medicine·Robin M WarrenPaul D van Helden
Feb 20, 2004·The Cochrane Database of Systematic Reviews·S Woldehanna, J Volmink
May 26, 2004·Proceedings. Biological Sciences·M Gabriela M GomesGraham F Medley
Apr 7, 2005·Lancet·Kathryn DeRiemerAlfredo Ponce-de-León
Apr 16, 2005·American Journal of Respiratory and Critical Care Medicine·Suzanne VerverPaul D van Helden
Jun 9, 2005·JAMA : the Journal of the American Medical Association·Christopher DyeMario C Raviglione
Jun 11, 2005·American Journal of Respiratory and Critical Care Medicine·Annelies van RieRobin M Warren
Jul 20, 2005·The Journal of Infectious Diseases·Amy K BarczakClifton E Barry
Jul 28, 2005·Tropical Medicine & International Health : TM & IH·Dermot MaherHaileyesus Getahun
Oct 4, 2005·Nature Reviews. Immunology·Paul NunnMario Raviglione

❮ Previous
Next ❯

Citations

Apr 17, 2008·Journal of Mathematical Biology·Nicolas BacaërBrian Williams
Dec 17, 2008·Bulletin of Mathematical Biology·Caroline ColijnMegan Murray
Aug 30, 2007·The Journal of Infectious Diseases·Charles D WellsKarin Weyer
May 11, 2013·American Journal of Epidemiology·Ian H SpicknallJoseph N S Eisenberg
Mar 5, 2008·Current Opinion in Infectious Diseases·J Lucian DavisLaurence Huang
Sep 29, 2011·HIV Medicine·A L PozniakUNKNOWN BHIVA Guidelines Subcommittee
Apr 12, 2013·Science Translational Medicine·Harriet L MillsCaroline Colijn
Feb 8, 2011·American Journal of Respiratory and Critical Care Medicine·N Sarita ShahNeel R Gandhi
Feb 12, 2010·BMC Infectious Diseases·Catherine F HoulihanMarie-Louise Newell
Jan 1, 2008·Operations Research·Elisa F LongMargaret L Brandeau
Jan 27, 2007·PLoS Medicine·Marc LipsitchBruce R Levin
Jan 26, 2010·PloS One·María S SánchezWayne M Getz
Aug 8, 2009·Future Microbiology·Ben J MaraisPeter R Donald
Jun 25, 2009·Bulletin of the World Health Organization·David W Dowdy, Richard E Chaisson
Oct 31, 2012·Bulletin of the World Health Organization·Hsien-Ho LinTed Cohen
Dec 19, 2013·Computational and Mathematical Methods in Medicine·E LunguN J Malunguza
Mar 5, 2011·The Lancet Infectious Diseases·Pia Abel zur WieschSebastian Bonhoeffer
Jun 2, 2007·Journal of Theoretical Biology·Caroline ColijnMegan Murray
Apr 29, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Amber KunkelTed Cohen
Mar 11, 2015·The Lancet. Diabetes & Endocrinology·Sung-Ching PanHsien-Ho Lin
Apr 17, 2015·Journal of the Royal Society, Interface·Leonid ChindelevitchTed Cohen
Jun 21, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Roos E BarthAndy I M Hoepelman
May 28, 2013·Mathematical Biosciences·Cristiana J Silva, Delfim F M Torres
Sep 28, 2016·Bulletin of Mathematical Biology·Alexander B BeamsFrederick R Adler
Jun 24, 2017·Epidemics·Romain RagonnetEmma S McBryde
Nov 2, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James M TrauerDavid W Dowdy
Feb 1, 2009·Expert Review of Respiratory Medicine·Ted CohenMegan Murray
Aug 30, 2017·The Cochrane Database of Systematic Reviews·Moleen ZunzaHeather J Zar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.